vs
Side-by-side financial comparison of Dexcom (DXCM) and F5, Inc. (FFIV). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $822.5M, roughly 1.5× F5, Inc.). F5, Inc. runs the higher net margin — 21.9% vs 21.2%, a 0.7% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 7.3%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 9.9%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
F5, Inc. is an American technology company specializing in application security, multi-cloud management, online fraud prevention, application delivery networking (ADN), application availability and performance, and network security, access, and authorization.
DXCM vs FFIV — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $1.3B | $822.5M |
| Net Profit | $267.3M | $180.1M |
| Gross Margin | 62.9% | 81.5% |
| Operating Margin | 25.6% | 26.0% |
| Net Margin | 21.2% | 21.9% |
| Revenue YoY | 21.6% | 7.3% |
| Net Profit YoY | 153.6% | 8.2% |
| EPS (diluted) | $0.67 | $3.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $822.5M | ||
| Q3 25 | $1.2B | $810.1M | ||
| Q2 25 | $1.2B | $780.4M | ||
| Q1 25 | $1.0B | $731.1M | ||
| Q4 24 | $1.1B | $766.5M | ||
| Q3 24 | $994.2M | $746.7M | ||
| Q2 24 | $1.0B | $695.5M |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $180.1M | ||
| Q3 25 | $283.8M | $190.5M | ||
| Q2 25 | $179.8M | $189.9M | ||
| Q1 25 | $105.4M | $145.5M | ||
| Q4 24 | $151.7M | $166.4M | ||
| Q3 24 | $134.6M | $165.3M | ||
| Q2 24 | $143.5M | $144.1M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 81.5% | ||
| Q3 25 | 60.5% | 82.2% | ||
| Q2 25 | 59.5% | 81.0% | ||
| Q1 25 | 56.9% | 80.7% | ||
| Q4 24 | 58.9% | 81.7% | ||
| Q3 24 | 59.7% | 80.8% | ||
| Q2 24 | 62.4% | 80.4% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 26.0% | ||
| Q3 25 | 20.1% | 25.4% | ||
| Q2 25 | 18.4% | 25.2% | ||
| Q1 25 | 12.9% | 21.7% | ||
| Q4 24 | 17.0% | 26.8% | ||
| Q3 24 | 15.3% | 25.6% | ||
| Q2 24 | 15.7% | 23.4% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 21.9% | ||
| Q3 25 | 23.5% | 23.5% | ||
| Q2 25 | 15.5% | 24.3% | ||
| Q1 25 | 10.2% | 19.9% | ||
| Q4 24 | 13.6% | 21.7% | ||
| Q3 24 | 13.5% | 22.1% | ||
| Q2 24 | 14.3% | 20.7% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $3.10 | ||
| Q3 25 | $0.70 | $3.25 | ||
| Q2 25 | $0.45 | $3.25 | ||
| Q1 25 | $0.27 | $2.48 | ||
| Q4 24 | $0.37 | $2.82 | ||
| Q3 24 | $0.34 | $2.79 | ||
| Q2 24 | $0.35 | $2.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $1.2B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $3.5B |
| Total Assets | $6.3B | $6.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $1.2B | ||
| Q3 25 | $1.8B | $1.3B | ||
| Q2 25 | $1.2B | $1.4B | ||
| Q1 25 | $904.9M | $1.3B | ||
| Q4 24 | $606.1M | $1.2B | ||
| Q3 24 | $621.2M | $1.1B | ||
| Q2 24 | $939.2M | $935.6M |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $3.5B | ||
| Q3 25 | $2.7B | $3.6B | ||
| Q2 25 | $2.6B | $3.5B | ||
| Q1 25 | $2.3B | $3.3B | ||
| Q4 24 | $2.1B | $3.2B | ||
| Q3 24 | $2.0B | $3.1B | ||
| Q2 24 | $2.4B | $3.0B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $6.3B | ||
| Q3 25 | $7.5B | $6.3B | ||
| Q2 25 | $7.3B | $6.1B | ||
| Q1 25 | $6.8B | $5.9B | ||
| Q4 24 | $6.5B | $5.9B | ||
| Q3 24 | $6.4B | $5.6B | ||
| Q2 24 | $6.8B | $5.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $159.2M |
| Free Cash FlowOCF − Capex | — | $149.5M |
| FCF MarginFCF / Revenue | — | 18.2% |
| Capex IntensityCapex / Revenue | — | 1.2% |
| Cash ConversionOCF / Net Profit | — | 0.88× |
| TTM Free Cash FlowTrailing 4 quarters | — | $861.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $159.2M | ||
| Q3 25 | $659.9M | $208.1M | ||
| Q2 25 | $303.0M | $282.2M | ||
| Q1 25 | $183.8M | $256.6M | ||
| Q4 24 | $301.4M | $202.8M | ||
| Q3 24 | $199.5M | $246.5M | ||
| Q2 24 | $279.4M | $159.0M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $149.5M | ||
| Q3 25 | $579.4M | $191.9M | ||
| Q2 25 | $208.9M | $273.7M | ||
| Q1 25 | $96.8M | $246.1M | ||
| Q4 24 | $176.8M | $194.7M | ||
| Q3 24 | $88.3M | $240.4M | ||
| Q2 24 | $213.3M | $153.1M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 18.2% | ||
| Q3 25 | 47.9% | 23.7% | ||
| Q2 25 | 18.1% | 35.1% | ||
| Q1 25 | 9.3% | 33.7% | ||
| Q4 24 | 15.9% | 25.4% | ||
| Q3 24 | 8.9% | 32.2% | ||
| Q2 24 | 21.2% | 22.0% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 1.2% | ||
| Q3 25 | 6.7% | 2.0% | ||
| Q2 25 | 8.1% | 1.1% | ||
| Q1 25 | 8.4% | 1.4% | ||
| Q4 24 | 11.2% | 1.1% | ||
| Q3 24 | 11.2% | 0.8% | ||
| Q2 24 | 6.6% | 0.8% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 0.88× | ||
| Q3 25 | 2.33× | 1.09× | ||
| Q2 25 | 1.69× | 1.49× | ||
| Q1 25 | 1.74× | 1.76× | ||
| Q4 24 | 1.99× | 1.22× | ||
| Q3 24 | 1.48× | 1.49× | ||
| Q2 24 | 1.95× | 1.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
FFIV
| Services | $412.2M | 50% |
| Products | $410.3M | 50% |